Clinical Trials Directory

Trials / Completed

CompletedNCT02673411

Ultrasonography SWE for Hepatic Fibrosis Evaluation

Diagnostic Performance of Shear Wave Elastography for Fibrosis Evaluation: Preliminary Study

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to measure diagnostic performance of ultrasound shear wave elastography to detect advanced hepatic fibrosis.

Detailed description

Hepatic fibrosis causes liver dysfunction and HCC. Since hepatic fibrosis is reversible dynamic condition, its monitoring is important to predict long term outcome and to determine treatment plan. The reference of standard to diagnose hepatic fibrosis is biopsy, but recently non-invasive method such as stiffness imaging has been drawing a lot of attention. In this study, ultrasound shear wave elastography will be performed and its diagnostic performance to detect advanced hepatic fibrosis (= \> F2) will be measured using histologic grade as a reference.

Conditions

Interventions

TypeNameDescription
DEVICEultrasound shear wave elastographyultrasound shear wave elastography is performed in GE ultrasound scanner according to guidelines of ultrasound elastography.

Timeline

Start date
2016-03-03
Primary completion
2016-09-27
Completion
2017-01-16
First posted
2016-02-03
Last updated
2021-03-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02673411. Inclusion in this directory is not an endorsement.